精神分裂症中小胶质细胞激活的遗传贡献
研究利用精神分裂症不一致单卵双胞胎与健康个体来源的诱导多能干细胞衍生小胶质细胞,比较转录与功能差异。患者小胶质细胞炎症相关基因表达升高、对IL1β反应减弱,但迁移与吞噬功能无显著差异,未见明确过度激活的功能证据。
要点
- 患者小胶质细胞炎症相关基因表达升高,但对IL1β反应减弱。
- 迁移与吞噬活性无显著差异,未见明确过度激活的功能迹象。
- RNA测序提示细胞外基质相关信号异常,MHC II类受体上调仅见于患者小胶质细胞。
核心结论
- 精神分裂症患者小胶质细胞存在炎症反应与细胞外基质相关基因表达异常,但未导致小胶质细胞激活增强。
研究设计与样本
- 利用精神分裂症不一致单卵双胞胎与健康个体,构建人诱导多能干细胞衍生小胶质细胞,比较转录与功能差异。
主要发现
- 患者小胶质细胞多种常见炎症相关基因表达较健康个体升高。
- 患者小胶质细胞对白细胞介素1β(IL1β)处理反应减弱,迁移或吞噬活性无显著差异。
- IPA分析显示细胞外基质信号异常;RNA测序预测细胞外基质结构成分GO术语下调及肝纤维化通路激活为患者与未患病双胞胎小胶质细胞共享,MHC II类受体上调仅见于患者小胶质细胞。
- 患者小胶质细胞对氯氮平、米诺环素及萝卜硫素处理反应异质。
临床怎么用
- 提示精神分裂症小胶质细胞以转录异常为主,不宜仅凭炎症基因升高推断小胶质细胞过度激活。
- 氯氮平、米诺环素及萝卜硫素对患者小胶质细胞反应异质,个体化用药需进一步验证。
局限性
- 作者指出由于缺乏合适的人源细胞模型,小胶质细胞在精神分裂症中的作用研究仍不充分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Several lines of evidence indicate the involvement of neuroinflammatory processes in the pathophysiology of schizophrenia (SCZ). Microglia are brain resident immune cells responding toward invading pathogens and injury-related products, and additionally, have a critical role in improving neurogenesis and synaptic functions. Aberrant activation of microglia in SCZ is one of the leading hypotheses for disease pathogenesis, but due to the lack of proper human cell models, the role of microglia in SCZ is not well studied. We used monozygotic twins discordant for SCZ and healthy individuals to generate human induced pluripotent stem cell-derived microglia to assess the transcriptional and functional differences in microglia between healthy controls, affected twins and unaffected twins. The microglia from affected twins had increased expression of several common inflammation-related genes compared to healthy individuals. Microglia from affected twins had also reduced response to interleukin 1 beta (IL1β) treatment, but no significant differences in migration or phagocytotic activity. Ingenuity Pathway Analysis (IPA) showed abnormalities related to extracellular matrix signaling. RNA sequencing predicted downregulation of extracellular matrix structure constituent Gene Ontology (GO) terms and hepatic fibrosis pathway activation that were shared by microglia of both affected and unaffected twins, but the upregulation of major histocompatibility complex (MHC) class II receptors was observed only in affected twin microglia. Also, the microglia of affected twins had heterogeneous response to clozapine, minocycline, and sulforaphane treatments. Overall, despite the increased expression of inflammatory genes, we observed no clear functional signs of hyperactivation in microglia from patients with SCZ. We conclude that microglia of the patients with SCZ have gene expression aberrations related to inflammation response and extracellular matrix without contributing to increased microglial activation.
引用
- Koskuvi M, Pörsti E, Hewitt T, et al. Genetic contribution to microglial activation in schizophrenia. Mol Psychiatry. 2024. PMID: 38519640. doi:10.1038/s41380-024-02529-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。